← FDA Drug Approvals (Drugs@FDA)

BRIVARACETAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SHANDONG · Approved 2026-07-13

Drug application

FDA Application #

ANDA219766

Application type

Abbreviated New Drug Application (Generic)

Brand name

BRIVARACETAM

Generic name

Brivaracetam

Active ingredients

BRIVARACETAM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

SHANDONG

First approval

2026-07-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown